Clinical Trials
-
Identification of Biomarkers That Can Predict Progression from Latent Tuberculosis Infection to
Study Location: India
Eligibility: Adult, Pediatric, Household contacts
Enrollment:
ACTIV-2/A5401: Adaptive Platform Treatment for Outpatients with COVID-19 (Adapt Out COVID)
Study Location: BaltimoreIndia
Eligibility: Adults
Enrollment:
P2026: Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs during Pregnancy and
Study Location: BaltimoreIndia
Eligibility: Preg/postpartum women. Infants
Enrollment:
The Pharmacokinetics, Safety and Acceptability of New Child-Friendly Formulations of Clofazimine and
Study Location: India
Eligibility: Pediatrics
Enrollment:
Impact of Tuberculosis Infection on HIV-1 Antibody Response (NWCS501)
Study Location: BaltimoreIndia
Eligibility: Adults, adolescents
Enrollment:
A5300B/I2003B/PHOENIX, Protecting Households On Exposure to Newly Diagnosed Index
Study Location: India
Eligibility: Men and women age greater than or equal to 18 year
Enrollment:
P2010: Phase III Study of the Virologic Efficacy and Safety of Dolutegravir-Containing versus
Study Location: India
Eligibility: HIV-1-infected pregnant women initiating antiretroviral therapy at 14-28 weeks gestation, and their infants
Enrollment:
P2005: A Phase I/II Open-Label, Single-Arm Study to Evaluate the Pharmacokinetics, Safety,
Study Location: India
Eligibility: HIV-infected and HIV-uninfected infants, children, and adolescents less than 18 years of age with confirmed or probable MDR-TB.
Enrollment:
A5253: Sensitivity and Specificity of Mycobacterium Tuberculosis Screening and Diagnostics in
Study Location: India
Eligibility: Ages Eligible for Study: 13 Years and older (Child, Adult, Senior) Sexes Eligible for Study: All Accepts...
Enrollment: